Skip to main content
. 2024 Sep 25;38(12):2653–2662. doi: 10.1038/s41375-024-02410-8

Fig. 2. Progression-free and overall survival for patients with LBCL (N = 157).

Fig. 2

Per IRC assessment for the overall population (A, B) and by best overall response per IRC (C, D). CI confidence interval, CR complete response, IRC Independent Review Committee, LBCL large B-cell lymphoma, OS overall survival, PFS progression-free survival, PR partial response.